Serial Number | 97273725 |
Word Mark | ELEUSIS |
Filing Date | Friday, February 18, 2022 |
Status | 700 - REGISTERED |
Status Date | Tuesday, October 24, 2023 |
Registration Number | 7198880 |
Registration Date | Tuesday, October 24, 2023 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, August 8, 2023 |
Goods and Services | Research and development in the field of medical uses of psychedelic drugs |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, February 23, 2022 |
Primary Code | 042 |
First Use Anywhere Date | Friday, April 30, 2021 |
First Use In Commerce Date | Friday, April 30, 2021 |
Party Name | Eleusis Therapeutics US, Inc. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10005 |
Party Name | Eleusis Therapeutics US, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10005 |
Party Name | Eleusis Therapeutics US, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10005 |
Event Date | Event Description |
Tuesday, October 24, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, October 24, 2023 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, August 8, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, August 8, 2023 | PUBLISHED FOR OPPOSITION |
Wednesday, July 19, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, July 5, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, January 4, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Wednesday, January 4, 2023 | LETTER OF SUSPENSION E-MAILED |
Wednesday, January 4, 2023 | SUSPENSION LETTER WRITTEN |
Saturday, December 3, 2022 | ASSIGNED TO EXAMINER |
Wednesday, February 23, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |